CLDF Title
Home | Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Reuters Health Information (2007-12-24): Japan PM says wants to help all hepatitis patients

Public Health

Japan PM says wants to help all hepatitis patients

Last Updated: 2007-12-24 9:48:18 -0400 (Reuters Health)

TOKYO (Reuters) - Japan's prime minister said on Sunday his party will draft legislation aimed at helping thousands of hepatitis patients, the latest development in a high-profile scandal that has drawn voter anger.

At least 10,000 people are believed to have contracted hepatitis C from tainted blood products, most notably fibrinogen used to stop haemorrhaging during surgery or childbirth. The drug was used in Japan even after it was withdrawn from the United States in 1977.

"Steps will be taken to provide aid to all the hepatitis sufferers," Prime Minister Yasuo Fukuda told reporters.

On Thursday, hepatitis patients rejected a government compensation proposal.

The prime minister said he hoped to be able to present the bill during the current session of parliament.

A group of patients seeking compensation had sued the government and drug makers, but had rejected a settlement proposal by a regional court earlier this month, saying it would only provide aid to a limited number of sufferers.

The group has been calling on the Japanese government to make a political decision on the matter.

Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Live CME Meetings
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2016 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.